STOCK TITAN

SOFGEN PHARMA S.A WTS (PRCWF) Debt by Year

PRCWF

SOFGEN PHARMA S.A WTS carried $23.8M in long-term debt against $30.3M in cash and equivalents at the end of fiscal year 2024. This represents a decrease of 20.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters SOFGEN PHARMA S.A WTS has filed alongside them.

FY2024 annual
Long-Term Debt $23.8M
Cash & Equivalents $30.3M
YoY -20.2%
5Y CAGR -43.7%
Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRCWF Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Long-Term Debt$23.8M-20.2%$29.8M+18.6%$25.1M+14.8%$21.9M-17.5%$26.5M-93.7%$420.4M
Cash & Equivalents$30.3M+73.1%$17.5M-59.3%$43.0M-40.4%$72.1M+1605.2%$4.2M+107.1%$2.0M

PRCWF Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2410-KQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K
Long-Term Debt$23.8M-20.2%$29.8M+18.6%N/A$25.1M+14.8%N/A$21.9M-17.5%$26.5M-93.7%$420.4M+37.8%$305.2M
Cash & Equivalents$30.3M+73.1%$17.5M-59.3%$11.5M-69.3%$43.0M-40.4%$37.6M$72.1M+1605.2%$4.2M+107.1%$2.0M-28.2%$2.8M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More SOFGEN PHARMA S.A WTS financials

Frequently Asked Questions

What was SOFGEN PHARMA S.A WTS's long-term debt in fiscal year 2024?

SOFGEN PHARMA S.A WTS carried $23.8M in long-term debt against $30.3M in cash and equivalents at the end of fiscal year 2024.

How fast is SOFGEN PHARMA S.A WTS's long-term debt growing?

SOFGEN PHARMA S.A WTS (PRCWF) long-term debt fell by 20.2% year over year, from $29.8M to $23.8M in fiscal year 2024.

How has SOFGEN PHARMA S.A WTS's long-term debt changed over the years?

Across the 6 fiscal years this page covers, SOFGEN PHARMA S.A WTS (PRCWF) long-term debt went from $420.4M in fiscal year 2019 to $23.8M in fiscal year 2024.

SOFGEN PHARMA S.A WTS (PRCWF) reported $23.8M in long-term debt in Q4 2024. This represents a decrease of 20.2% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what SOFGEN PHARMA S.A WTS (PRCWF) reported on that line in every period on record.